1.Magill, SS, Edwards, JR, Bamberg, W, et al.Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198–1208.
2.Evans, CT, Safdar, N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin Infect Dis 2015;60 suppl 2:S66–S71.
3.Kwon, JH, Olsen, MA, Dubberke, ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin N Am 2015;29:123–134.
4.Kyne, L, Hamel, MB, Polavaram, R, Kelly, CP. Healthcare costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346–353.
5.Stevens, V, Dumyati, G, Fine, LS, Fisher, SG, van Wijngaarden, E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011;53:42–48.
6.Brown, KA, Khanafer, N, Daneman, N, Fisman, DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 2013;57:2326–2332.
7.McDonald, LC, Owings, M, Jernigan, DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006;12:409–415.
8.Pepin, J, Valiquette, L, Cossette, B. Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005;173:1037–1042.
9.Campbell, RR, Beere, D, Wilcock, GK, Brown, EM. Clostridium difficile in acute and long-stay elderly patients. Age Ageing 1988;17:333–336.
10.Howell, MD, Novack, V, Grgurich, P, et al.Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170:784–790.
11.Dubberke, ER, Reske, KA, Olsen, MA, et al.Evaluation of Clostridium difficile–associated disease pressure as a risk factor for C. difficile–associated disease. Arch Intern Med 2007;167:1092–1097.
12.Miller, AC, Polgreen, LA, Cavanaugh, JE, Polgreen, PM. Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI. Am J Infect Control 2016;44:825–829.
13.Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J, Jr . Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459–477.
14.Kim, KH, Fekety, R, Batts, DH, et al.Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981;143:42–50.
15.Bobulsky, GS, Al-Nassir, WN, Riggs, MM, Sethi, AK, Donskey, CJ. Clostridium difficile skin contamination in patients with C. difficile–associated disease. Clin Infect Dis 2008;46:447–450.
16.Sethi, AK, Al-Nassir, WN, Nerandzic, MM, Bobulsky, GS, Donskey, CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010;31:21–27.
17.Landelle, C, Verachten, M, Legrand, P, Girou, E, Barbut, F, Brun-Buisson, C. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol 2014;35:10–15.
18.Shrestha, SK, Sunkesula, VC, Kundrapu, S, Tomas, ME, Nerandzic, MM, Donskey, CJ. Acquisition of Clostridium difficile on hands of healthcare personnel caring for patients with resolved C. difficile infection. Infect Control Hosp Epidemiol 2016;37:475–477.
19.Shaughnessy, MK, Micielli, RL, DePestel, DD, et al.Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011;32:201–206.
20.McDonald, LC, Gerding, DN, Johnson, S, et al.Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1–e48.
21.Eyre, DW, Cule, ML, Wilson, DJ, et al.Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013;369:1195–1205.
22.Tschudin–Sutter, S, Carroll, KC, Tamma, PD, et al.Impact of toxigenic Clostridium difficile colonization on the risk of subsequent C. difficile infection in intensive care unit patients. Infect Control Hosp Epidemiol 2015;36:1324–1329.
23.Bruminhent, J, Wang, ZX, Hu, C, et al.Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 2014;20:1329–1334.
24.Smith, CM, Le Comber, SC, Fry, H, Bull, M, Leach, S, Hayward, AC. Spatial methods for infectious disease outbreak investigations: systematic literature review. Euro Surveill 2015;20.
25.Curtis, DE, Hlady, CS, Kanade, G, Pemmaraju, SV, Polgreen, PM, Segre, AM. Healthcare worker contact networks and the prevention of hospital-acquired infections. PloS One 2013;8:e79906.
26.Knox, G. The detection of space–time interactions. Applied Statistics 1964;13:25–29.
27.Takaguchi, T, Masuda, N, Holme, P. Bursty communication patterns facilitate spreading in a threshold-based epidemic dynamics. PloS One 2013;8:e68629.
28.Akbarpour, M, Jackson, MO. Diffusion in networks and the virtue of burstiness. Proc Nat Acad Sci U S A 2018;115:e6996–e7004.
29.Cao, J. Th size of the connected components of excursion sets of X2, t and F fields. Adv in Appl Prob 1999;31:579–595.
30.Mantel, N. The detection of disease clustering and a generalized regression approach. Cancer Res 1967;27:209–220.
31.Bartlett, JG. How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy. Infect Dis Clin N Am 2013;27:149–155.
32.Ottosen, J, Evans, H. Pneumonia: challenges in the definition, diagnosis, and management of disease. Surg Clin N Am 2014;94:1305–1317.
33.Bowerman, TJ, Zhang, J, Waite, LM. Antibacterial treatment of aspiration pneumonia in older people: a systematic review. Clin Intervent Aging 2018;13:2201–2213.
34.Polgreen, PM, Yang, M, Bohnett, LC, Cavanaugh, JE. A time-series analysis of Clostridium difficile and its seasonal association with influenza. Infect Control Hosp Epidemiol 2010;31:382–387.
35.Stiller, A, Salm, F, Bischoff, P, Gastmeier, P. Relationship between hospital ward design and healthcare-associated infection rates: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2016;5:51.
36.Dettenkofer, M, Seegers, S, Antes, G, Motschall, E, Schumacher, M, Daschner, FD. Does the architecture of hospital facilities influence nosocomial infection rates? A systematic review. Infect Control Hosp Epidemiol 2004;25:21–25.
37.Rexach, CE, Tang-Feldman, YJ, Cohen, SH. Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect Control Hosp Epidemiol 2005;26:691–696.
38.Hornbeck, T, Naylor, D, Segre, AM, Thomas, G, Herman, T, Polgreen, PM. Using sensor networks to study the effect of peripatetic healthcare workers on the spread of hospital-associated infections. J Infect Dis 2012;206:1549–1557.